SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
May 6, 2021
Document Date
May 6, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Talaris Therapeutics, Inc.
Issuer
TALARIS THERAPEUTICS, INC.
Filer
Clarus Lifesciences III, L.P.
Print Page
RSS Feeds
Email Alerts
Email Page